Year archive

Revive Therapeutics Ltd. — 2024 filings

All 22 regulatory filings released by Revive Therapeutics Ltd. (RVV) in 2024, sourced directly from the official regulator.

22 Filings

2024 Period

2024 filings (22)

Filing	Released	Lang
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-11-30	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-11-30	English
Interim MD&A - English.pdf Management Reports Q1 2025	2024-11-30	English
Interim financial statements/report – English.pdf Interim / Quarterly Report Q1 2025	2024-11-30	English
News release - English.pdf Regulatory Filings	2024-11-12	English
News release - English.pdf Regulatory Filings	2024-10-31	English
News release - English.pdf Regulatory Filings	2024-07-02	English
News release - English.pdf Regulatory Filings	2024-06-12	English
News release - English.pdf Regulatory Filings	2024-04-18	English
News release - English.pdf Regulatory Filings	2024-04-02	English
News release - English.pdf Regulatory Filings	2024-03-27	English
News release - English.pdf Regulatory Filings	2024-03-19	English
News release - English.pdf Regulatory Filings	2024-03-19	English
Report of exempt distribution (45-106F1).pdf Regulatory Filings	2024-03-04	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-02-29	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-02-29	English
Interim MD&A - English.pdf Regulatory Filings	2024-02-29	English
Interim financial statements/report – English.pdf Regulatory Filings	2024-02-29	English
News release - English.pdf Regulatory Filings	2024-02-26	English
Report of exempt distribution (45-106F1).pdf Regulatory Filings	2024-02-23	English
News release - English.pdf Regulatory Filings	2024-01-25	English
News release - English.pdf Regulatory Filings	2024-01-16	English